Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Control and containment key to combating avian influenza

Containing the bird flu virus to the greatest extent possible and reducing the risk of infection in poultry and farmed free-range ducks will help to prevent a global human influenza pandemic, the Food and Agriculture Organization (FAO) has announced.

24 Feb 2005

$5.53 million to help strengthen Canada's nursing workforce

Canadian Health Minister Ujjal Dosanjh has announced federal funding of $5.53 million to help strengthen Canada's nursing workforce paying tribute to the critical role nurses play in Canada's health care system. Minister Dosanjh made this announcement in a speech to the Nursing Leadership Conference.

17 Feb 2005

Tentative approval of co-packaged lamivudine/zidovudine fixed dose combination tablets and nevirapine tablets

The Food and Drug Administration (FDA) has announced the tentative approval of a co-packaged antiretroviral drug regimen manufactured by Aspen Pharmacare of South Africa for the treatment of HIV-1 infection in adults.

26 Jan 2005

New highly active agents against leishmaniasis

Parasitic diseases, especially leishmaniases and trypanosomiases, kill hundreds of thousands of people every year in the world, mainly in the countries of the South. The most severe form of leishmaniosis (kala-azar, the visceral form), induced by Leishmania donovani and L. infantum, affects about 500 000 people per year and proves fatal if no treatment is given.

25 Jan 2005

School influenza vaccinations best strategy for slowing flu transmission

The best strategy for minimizing future influenza morbidity and mortality would be to concentrate vaccinations in school children and high-risk groups, according to a new research commentary by scientists at Emory University.

25 Jan 2005

ID Biomedical begins development of pandemic influenza vaccine

ID Biomedical announced today that it has begun development of an experimental ("mock") vaccine against a strain of the influenza virus, H5N1, that experts believe could cause a deadly worldwide epidemic (pandemic) of influenza.

19 Jan 2005

Safety established for Vaxin's first flu vaccine in clinical trial

Vaxin Inc., a privately-held biotechnology company, has demonstrated, in a Phase I human clinical study, that the company's recombinant influenza vaccine provides a potential alternative to traditional flu vaccines.

12 Jan 2005

Ranbaxy files anti-retrovirals (ARVs) to the U.S. FDA

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has so far made three filings of its Anti-Retrovirals (ARVs) to the U.S. FDA for its approval under the expedited review process of the President's Emergency Plan for AIDS Relief (PEPFAR).

10 Jan 2005

New compound Viprovex could save millions

The World Health Organization (WHO) and influenza experts worldwide are concerned that the recent appearance and widespread distribution of an avian influenza virus (Influenza A/H5N1) has the potential to ignite the next pandemic and potentially kill millions.

21 Dec 2004

HHS purchases 1.2 million doses of GSK's Fluarix flu vaccine

HHS Secretary Tommy G. Thompson has announced that the Food and Drug Administration authorized the use of GlaxoSmithKline influenza vaccine, Fluarix, in the United States under an Investigational New Drug application.

8 Dec 2004

Research suggests that lack of sleep may be contributing to the obesity pandemic

The recent rise in obesity may be partly due to the reduced amount of time we spend asleep, according to new research from the University of Bristol, UK.

6 Dec 2004

Canadian experts gather to address emerging issues in immunization

More than 800 physicians, nurses, public health experts and researchers are gathering in Montreal this week for the sixth Canadian Immunization Conference, running Dec. 5-8, 2004. The conference is being hosted by the Public Health Agency of Canada and the Canadian Paediatric Society.

6 Dec 2004

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

Australian Medical Association Vice President, Dr Mukesh Haikerwal, has said the Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning.

6 Dec 2004

Human endogenous retroviruses (HERVs)

Human endogenous retroviruses (HERVs) have been the subject of a great deal of investigation in recent years. It has been established that HERVs cause some genetic diseases and there is strong circumstantial evidence for a link to some types of cancer and autoimmune diseases, but what else do we need to know about these unique organisms?

4 Dec 2004

Study gives U.S.a 'C' grade for reproductive health

In a comprehensive study released today by Population Action International (PAI) - an independent policy and research organization based in Washington, D.C. - the United States ranks 16th and receives a "C" on a list of 21 donor countries graded according to their financial and political support for international reproductive health and population programs.

2 Dec 2004

Joint collaboration to fight avian influenza

Recognizing the pandemic potential and the threat to public health posed by the Avian Influenza, Health Ministers and senior officials of thirteen countries from Southeast and East Asian countries have pledged to accelerate joint collaboration in fighting the disease.

29 Nov 2004

SARS outbreak unlikely according to World Health Organization

The regional head of the World Health Organization said today that it was possible the region would experience SARS cases this winter, but he doubted the situation would be serious. "I don't think a large outbreak is likely," said Dr Shigeru Omi, Regional Director of WHO's Western Pacific Regional Office.

29 Nov 2004

$10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia

HHS Secretary Tommy G. Thompson has announced four new grants totaling $10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia, four nations that have been hard hit by the AIDS epidemic.

19 Nov 2004

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Generic antipsychotic drugs can protect brain cells from a virus that causes a fatal nervous system disorder, according to research conducted at Brown University and Case Western Reserve University.

18 Nov 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004